Stereotactic ablative radiotherapy effective option for primary renal cell carcinoma

Use of stereotactic ablative radiotherapy (SABR) effectively treated patients with primary renal cell carcinoma and had an acceptable effect on patient renal function, according to the results of a pooled analysis published in Cancer.
Cancer Network